Anita Chakraverty
Anita Chakraverty is a freelance medical journalist and science communicator. Outside work, she enjoys a good movie, long walks in the local woods, and trying to get into pretzel-like yoga poses.
Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle
Phase II Fail Ends Swiss-US Drug for Rare Kidney Disease
Oncopeptides’ Share Issue Bags €133M to Take Cancer Drug to Market
Phase III Failure Sinks Drug for Rare Neurological Disorder
€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating
Coronavirus Pandemic Bites into European Cancer Research
Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment
Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II
